QT Imaging Holdings (QTI) Investor presentation summary

Technology and innovation

• Developed a 3D breast imaging device using quantitative transmission imaging, cleared by the FDA for both transmission and reflection ultrasonic imaging of the breast.

• Technology offers high-resolution, no-radiation, painless scans, with diagnostic performance comparable to MRI but at lower cost and greater accessibility.

• Platform integrates proprietary hardware, advanced image reconstruction software, and AI-powered clinical decision tools for precision in breast health.

• Generates quantitative biomarkers (speed of sound, attenuation, reflection) for objective, reproducible tissue characterization and AI-driven analysis.

• Cloud-based SaaS platform enables automated image analysis, lesion segmentation, and continuous learning from clinical data.

Clinical and patient impact

• Provides a comprehensive, operator-independent imaging solution suitable for women with dense breasts, implants, or those under 40 not eligible for mammography.

• Reduces patient anxiety, scheduling complexity, and unnecessary interventions by offering a one-stop, painless, and efficient exam.

• Demonstrated higher diagnostic accuracy in dense breasts, identifying abnormalities missed by mammograms in 84% of cases in a mini-study.

• Enables early detection, therapy monitoring, and personalized medicine through quantitative imaging biomarkers.

• Supported by $18 million in NIH funding for supplemental imaging in women with dense breasts.

Business model and partnerships

• Operates a hybrid hardware and SaaS model, with recurring revenue from cloud-based analytics and biomarker services.

• Strategic distribution agreements in the USA (NXC Imaging/Canon), Saudi Arabia (Gulf Medical), and UAE (Al Naghi Medical), with committed minimum order quantities through 2028.

• Manufacturing partnership with Canon Medical Systems.

• Projected $39 million in 2026 contracted revenue from USA, Saudi Arabia, and UAE.

• Expanding clinical footprint with installations at major centers including Mayo Clinic, NIH, and commercial imaging centers.